How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer

KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer

(2015) S Renaud et al.   BRITISH JOURNAL OF CANCER

Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model

(2015) Patricia Alamo et al.   FASEB JOURNAL

Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis

(2015) Michel Gonzalez et al.   Future Oncology

A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells

(2015) Chih-Chien Chou et al.   Oncotarget

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer

(2015) Lloyd Pereira et al.   Frontiers in Oncology

Stromal Expression of Heat-Shock Protein 27 Is Associated with Worse Clinical Outcome in Patients with Colorectal Cancer Lung Metastases

(2015) Thomas Schweiger et al.   PLoS One

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

(2014) Samantha Kaufhold et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma

(2014) Stéphane Renaud et al.   Interactive Cardiovascular and Thoracic Surgery

Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer

(2014) S. Renaud et al.   Interactive Cardiovascular and Thoracic Surgery

Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

(2013) Georgios Karagkounis et al.   CANCER

Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking

(2013) Thomas Schweiger et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

(2012) Nathan T. Ihle et al.   JNCI-Journal of the National Cancer Institute

Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer

(2011) M. C. Garassino et al.   ANNALS OF ONCOLOGY

A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival

(2009) Anurag Singh et al.   CANCER CELL

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE